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Associations between Criteria Air Pollutants
and Asthma
Hillel S. Koren
Health Effects Research Laboratory, U.S. Environmental Protection Agency, Chapel Hill, North Carolina
The evidence that asthma is increasing in prevalence is becoming increasingly compelling. This trend has been demonstrated not only in the United
States, but also in the United Kingdom, New Zealand, Australia, and several other Western countries. In the United States, the increase is largest in
the group under 18 years of age. There is mounting evidence that certain environmental air pollutants are involved in exacerbating asthma. This is
based primarily on epidemiologic studies and more recent clinical studies. The U.S. Clean Air Act of 1970 provides special consideration to the class
of outdoor air pollutants referred to as criteria pollutants, including 03, sulfur dioxide (SO2), particulate matter (PM), NOR, CO, and Pb. Standards for
these pollutants are set by the U.S. Environmental Protection Agency with particular concern for populations at risk. Current evidence suggests that
asthmatics are more sensitive to the effects of 03, SO2, PM, and NO2, and are therefore at risk. High SO2 and particulate concentrations have been
associated with short-term increases in morbidity and mortality in the general population during dramatic air pollution episodes in the past. Controlled
exposure studies have clearly shown that asthmatics are sensitive to low levels of SO2. Exercising asthmatics exposed to SO2 develop bronchocon-
striction within minutes, even at levels of 0.25 ppm. Responses are modified by air temperature, humidity, and exercise level. Recent epidemiologic
studies have suggested that exposure to PM is strongly associated with morbidity and mortality in the general population and that hospital admis-
sions for bronchitis and asthma were associated with PM10 levels. In controlled clinical studies, asthmatics appear to be no more reactive to aerosols
than healthy subjects. Consequently, it is difficult to attribute the increased mortality observed in epidemiologic studies to specific effects demon-
strated in controlled human studies. Epidemiologic studies of hospital admissions for asthma have implicated 03 as contributing to the exacerbation
of asthma; however, most study designs could not separate the 03 effects from the concomitant effects of acid aerosols and SO2. Controlled
human clinical studies have suggested that asthmatics have similar changes in spirometry and airway reactivity in response to 03 exposure com-
pared to healthy adults. However, a possible role of 03 in worsening atopic asthma has recently been suggested in studies combining allergen chal-
lenge following exposure to 03. Attempts at identification of factors that predispose asthmatics to responsiveness to NO2 has produced
inconsistent results and requires further investigation. In summary, asthmatics have been shown to be a sensitive subpopulation relative to several
of the criteria pollutants. Further research linking epidemiologic, clinical, and toxicologic approaches is required to better understand and characterize
the risk of exposing asthmatics to these pollutants. - Environ Health Perspect 103(Suppl 6):235-242 (1995)
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Introduction
Asthma is a diffuse, inflammatory chronic
airway disease generally associated with
hyperreactivity to nonspecific bronchocon-
strictor drugs, in which eosinophils are
prominent among inflammatory cells. The
eosinophils and their specific products are
responsible in part for bronchial hyperreac-
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tivity and for airway epithelial damage and
desquamation.
Many patients with asthma are atopic,
i.e., have a genetically determined type of
immune reactivity that favors IgE response
to multiple environmental antigens. These
individuals may or may not develop clinical
asthma despite the existence of IgE-medi-
ated mucosal and skin reactivity to com-
mon environmental antigens. Allergic
asthma is, most commonly, an immediate
onset reaction (within 1 hr and often within
minutes of exposure) and results from the
local release of inflammatory mediators.
Such reactions are usually, although not
exclusively, affected by IgE antibody.
Asthmatic reactions may also be persistent
or have a late onset and it is possible that
other types of immune reactions play a
part (1-3). Recently it has been apparent
that cytokines play a role of particular
importance in the regulative antibody
responses (4). Interleukin 4 (IL-4) and
interferon y (IFNy) are the most important
cytokines with respect to the regulation of
IgE antibody. In mice, the initiation and
maintenance ofIgE responses is dependent
on the availability ofIL-4 (5). In contrast,
IFNy inhibits IgE production (6). In
humans, IL-4 and IFNy also have similar
reciprocal effects on IgE antibody (7).
Interestingly, there exists a functional het-
erogeneity among T helper (TH) cells, the
class ofT lymphocytes required for B lym-
phocytes to respond to antigen and
develop into antibody-producing plasma
cells. Two populations ofTH cells have
been described, designated TH. and TH2'
which differ in respect to the spectrum of
cytokines they produce following activa-
tion (Figure 1). Although both populations
secrete interleukin 3 (IL-3) and granulo-
cyte/macrophage colony-stimulating factor
(GM-CSF), only TH1 cells produce inter-
leukin 2 (IL-2), tumor necrosis factor
(TNF-,), and IFNy, and only TH2 cells
produce interleukins 4, 5, 6, and 10 (IL-4,
IL-4, IL-6, and IL-10) (8). Heterogeneity
among TH cells has recently been con-
firmed in humans (9), and there is emerg-
ing evidence that immediate-onset allergic
reactions in man are associated with the
selective activation ofTH2 cells. It appears
that conditions that favor the activation of
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Figure 1. Induction and elicitation of respiratory allergy.
TH2 cells and IL-4 production will facili-
tate IgE antibody responses and the devel-
opment of respiratory sensitization.
Variables that might affect the induction
ofT.2-type responses include the nature of
antigen, the route and duration of expo-
sure, genetic predisposition, and possibly
environmental factors.
Air pollution does not affect the health
of exposed persons with equal severity.
Certain subgroups of people potentially
exposed to air pollution can be identified as
particularly at-risk from the adverse health
effects of airborne pollutants. The U.S.
Environmental Protection Agency (U.S.
EPA) has described the population at-risk
as "...a segment of a defined population
exhibiting characteristics associated with
significantly higher probability ofdevelop-
ing a condition, illness, or other abnormal
status...." These subgroups have been
identified through clinics
demiologic studies ofthe
the six criteria pollutants
risk subgroups described I
are based on information
recent U.S. EPA criteria
to set the National Amb
Standards (NAAQS) an
(Table 1). For example, tI
scientific evidence that
much more sensitive (i.,
symptoms at relatively lot
to the effects ofsulfur di
the general healthy popuL
In the United States,
of 1970 established the p
ofthe nation's effort to (
tion and established the I
108 requires the U.S. El
pollutants that "...ma
anticipated to endanger p
station to issue air quality criteria documents for
torytract such pollutants that reflect "the latest sci-
entific knowledge useful in indicating the
kind and extent ofall identifiable effects on
public health and welfare which may be
Bronchoconstriction expected from the presence ofsuch pollu-
tants in the ambient air." The six criteria
pollutants, the primary standards, and
their permissible levels are shown in Table
Inflammatory 1. In the 1990 Amendments to the Clean
mediators Air Act, Congress gave the U.S. EPA
authority to impose technology-based stan-
dards to control specific toxic substances
(air toxics). The ultimate goal is to regulate
the list of 189 pollutants based on known
or anticipated health risks.
There is mounting evidence that asthma
prevalence, morbidity, and mortality are
)n increasing in the United States and many
other western countries. The reasons for
these trends are not clear but are probably
complex and involve a number of factors.
According to our present understanding,
the development ofclinical asthma requires
al, field, and epi- the presence of host factors and environ-
health effects of mental factors. Work in laboratory animals
The specific at- (10) and epidemiologic evidence (11) both
for each pollutant support the existence ofan intimate rela-
contained in the tionship between atmospheric pollution
documents used and IgE-mediated sensitization to environ-
)ient Air Quality mental antigens. The issue ofwhether air
id other sources pollution can increase the severity of
iere is very strong asthma in an already sensitized population
t asthmatics are is not resolved; this topic has recently been
e., respond with reviewed (12). Respiratory viruses also
w concentrations) seem to be an important cofactor, but their
oxide (SO2) than role is unclear. The evidence that asthma is
nation. increasing in prevalence is becoming
the Clean Air Act increasingly compelling based on trends
'ublic health basis demonstrated in the United States, across
control air pollu- Europe, New Zealand, Australia, and sev-
J.S. EPA. Section eral other countries (13). In the United
?A to identify air States, the increase is largest among chil-
y reasonably be dren and adolescents (14). It is still not
ublic health," and completely clear how much ofthe increase
Table 1. National ambient airquality standards.
Pollutant Primarystandardsa Type of average At-risk populations
03 0.12 ppm (235pg/mi3) Maximum daily 1 hr average Persons with preexisting respiratory disease, elderly persons, preadolescent children
PM10 50pg/M3 Annual arithmetic mean Preadolescent children (< 13 years old), elderly persons(.65 years old), persons with
150pg/M3 24 hr preexisting respiratory disease (COPD and asthma)
So0 0.03 ppm (80 mg/m3 Annual arithmetic mean Preadolescent children, persons with preexisting respiratory disease, elderly persons
0.14 ppm(365pg/mi) 24hrc
NO2 0.053 ppm(100pg/m3) Annual arithmetic mean Preadolescent children, persons with preexisting respiratory disease
CO 9 ppm(10mg/mi3) 8hrc Pregnant women, persons with preexisting coronary heart disease
35 ppm(40 mg/m3) 1 hrc
Pb 1.5pg/M3 Maximum quarterly average Children .5, pregnant women
Abbreviations: 03, ozone; PM10, particulate matter lessthan 10 pm aerodynamic diameter; SO2, sulfurdioxide; NO2, nitrogen dioxide; CO, carbon monoxide; Pb, lead. 'The pri-
mary standard is to protect against adverse health effects. bChronic obstructive pulmonary disease, including emphysema and chronic bronchitis. CNot to be exceeded more
than once a year.
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in prevalence is due to a real increase and
how much is due to increased recognition
on the part of the lay public and health
professionals. Asthma hospitalizations
increased during the 1970s and levelled off
during the 1980s for all but a few age
groups (14). These increases come at a
time when hospitalization for most condi-
tions has been decreasing, and greater use
has been made of extended emergency
room units and short-stay admissions.
Asthma mortality increased in the United
States during the 1980s for all ages (14). It
is important to note, however, that asthma
mortality in the United States is among the
lowest for the countries that have reliable
mortality statistics (13). Nevertheless, a
continuing trend toward increasing mortal-
ity is worrisome. It will take a number of
years to sort out why these trends for
asthma are occurring. Attention must be
focused on finding the causes and risk fac-
tors for asthma so that appropriate
intervention strategies can be developed.
The purpose ofthis report is to review
the available data that provides evidence
for an association between asthma and
exposure to selected criteria pollutants and
that focuses on clinical studies using
physiological and biochemical endpoints.
Responses ofAsthmatics to
Criteria Pollutants
Not all criteria pollutants have been shown
to have an effect on asthmatics (Table 1).
Therefore, the discussion below will focus
on those criteria pollutants that have been
shown to have pulmonary effects on asth-
matics, namely SO2, particulate matter less
than 10 pm aerodynamic diameter (PM10),
03, and NO2.
SulfurDioxide
Sulfur dioxide (SO2) is emitted primarily
by coal- and oil-fired plants and by indus-
trial processes involving fossil fuel combus-
tion, as sulfur is a natural contaminant of
these fossil fuels. SO2 and particles are
directly regulated under the Clean Air Act
whereas the possibility of a standard for
acid aerosols has only recently been consid-
ered by the U.S. EPA. Even though parti-
cles, sulfur oxides (SOX), and acid aerosols
are chemically distinct, they are all released
by fossil fuel combustion processes and are
usually present together as components of
a complex mixture.
Epidemiologic data indicate an associa-
tion between particles and acid aerosols
and increased mortality, although the asso-
ciation is notably weaker for SO2' The
epidemiologic studies are limited in that
the effects ofthese different pollutants can-
not be assessed separately. This can, how-
ever, be addressed in controlled chamber
exposure studies.
SO2 is a respiratory irritant that does
not cause substantial acute or chronic
adverse effects in animals exposed to ambi-
ent concentrations (15,16). Because SO2 is
50 times more soluble than CO2 in water
at 300C, it is mostly absorbed in the upper
airways in subjects at rest, although
increasing ventilation results in deposition
in deeper parts of the lung. Controlled
human studies ofhealthy subjects exposed
to SO2 at rest or with exercise have failed
to demonstrate effects on respiratory
mechanics at levels up to 1.0 ppm
(17-20). In contrast, exposure to low lev-
els ofSO2 does alter the lung function of
asthmatics (21,22). Asthmatic subjects
exercising in air containing SO2 develop
bronchoconstriction within minutes, even
at levels as low as 0.25 ppm. When asth-
matic subjects are briefly exposed to SO2,
many develop significant increases in air-
way resistance, especially with oral breath-
ing at a minute ventilation greater than 40
1/min (23-26). Spirometric functions
(e.g., forced expiratory volume in 1 sec;
FEV1) were also decreased in response to
exposure to 0.4 to 1.0 ppm SO2. The data
indicate heterogeneity in the response to
SO2 among asthmatics (27) and that indi-
vidual responses are relatively reproducible
(27,28). SO2 can be considered to have
comparable effects to those of nonsensitiz-
ing bronchoconstrictors, such as histamine
and methacholine, but are not comparable
to those ofspecific antigens and certain
occupational chemicals that can provoke
so-called late reactions.
The predominant acid aerosols are sul-
fate and bisulfate ions that are found in
solution in water droplets in the atmos-
phere. Because ofthe abundance ofammo-
nia in the atmosphere, sulfate is usually
found in one ofthe two above-mentioned
forms. Some short-term controlled inhala-
tion studies suggest that asthmatics are
more sensitive than normal subjects to
H2SO4 aerosols at concentrations in excess
ofthe high range ofobserved ambient levels
of acid aerosols in the United States
(29,30). Other studies, however, have failed
to confirm the susceptibility ofasthmatics
(31-33). One reason for the difference in
the results obtained from different laborato-
ries may be that endogenous respiratory
NH3 provides protection against inhaled
acidic pollutants. High oral respiratory
levels ofNH3 have been shown to inhibit
bronchoconstriction induced by H2SO4 in
exercising asthmatics (34). Taken together,
these studies show that an effect ofacid
aerosols clearly occurs in some asthmatics,
but with less consistency than the SO2
response. The variation in response ofasth-
matics to acid aerosols among various labo-
ratories awaits explanation.
Priculat Matter
The initial reference method for total sus-
pended particles (TSP) measured mass of
all suspended particles. In 1987, the EPA
restricted the NAAQS to the mass concen-
tration ofinhalable particles less than 10
pm aerodynamic diameter (PM10) (35)
(Table 1). The NAAQS for PM does not
specify chemical composition ofparticles.
The 10 pm size cutofffocuses monitoring
and regulatory efforts on particles ofa size
that would be deposited in and could dam-
age the lower airways and gas-exchanging
portions of the lung. So far, most of the
human health effects data of PM is based
on epidemiologic data. High particulate
and SO2 concentrations were associated
with substantial short-term increases in
morbidity and mortality during dramatic
air pollution episodes ofthe past (36-41).
The obvious increases in morbidity and
mortality that accompanied these episodes
and the frequency and severity ofrespira-
tory complaints left little doubt that pollu-
tion exposure caused the adverse effects.
Exposure to particulates was associated
with increases in respiratory symptoms
during the 1960s in Londoners with
chronic obstructive lung disease (COPD)
(37). Daily total mortality has recently
been reported to be positively associated
with TSP concentrations. An analysis of
data from Steubenville, Ohio, for 11 years
(1974-1984) showed a statistically
significant increase in daily total mortality
associated with TSP concentrations ofthe
previous day (42). A similar association
was shown in a study conducted in
Philadelphia (43). Analysis of cause-
specific mortality in Philadelphia showed
the strongest association with respiratory
mortality and, secondarily, with cardiovas-
cular mortality. Relatively few studies have
specifically assessed the association between
PM and asthma. Daily reports of respira-
tory symptoms were collected among a
panel of209 adult asthmatics residing in
Denver, Colorado (44). Hydrogen ion and
PM25 levels were associated with moderate
to severe cough and shortness ofbreath,
both ofwhich are indicators of asthma.
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Asthma medication use increased with
increasing PMIO in a panel of asthma
patients living in the Utah Valley (45,46).
The biological effect of particles is
determined by the physical and chemical
nature ofthe particle, the physics of the
deposition in the respiratory tract, and the
biologic events occurring in response to the
particle. There is a general beliefthat a dis-
turbing aspect ofthe epidemiologic findings
thus far is that effects appear independent
ofthe chemical composition ofthe parti-
cles. Approaches to understanding the
mechanisms) responsible for the biologic
effects ofparticles include in vivo instilla-
tion and inhalation ofparticles followed by
analyses oftissues and fluids for toxicologi-
cal changes indicative of a disease and in
vitro exposures ofparticles to pulmonary
cell types including macrophages and
epithelial cells. Intratracheal instillation of
particle suspensions directly into the lung
of rodents has been used to study direct
cytotoxic effects (47). Bronchopulmonary
lavage in animals at various times postexpo-
sure has enabled the performance ofassays
ofinflammation and edema for various par-
ticles (48,47). In vitrostudy ofparticles is a
useful approach to assess the response of
cells that may contribute to the inflamma-
tory process as it relates to interactions with
particles. Several studies describing the
responses ofalveolar macrophages (49,50)
to particles such as SiO2 and TiO2 have
been described. So far none ofthese studies
involved the use of pulmonary cells
obtained from asthmatic individuals. It is
noteworthy that recent studies with normal
human subjects exposed to instilled parti-
cles followed by bronchoalveolar lavage
(BAL) at different times revealed an
inflammatory response for 2 days following
the instillation ofthe particles as indicated
by neutrophilic infiltrates (51). Inflamma-
tion maybe exacerbated by alteration in the
deposition characteristics ofparticles in
compromised lungs. Again, no such experi-
ments have so far been performed with
asthmatic subjects.
Collectively, the epidemiologic studies
provide provocative evidence for adverse
pulmonary health effects associated with
particulate pollution. The association
between PM and acute mortality and mor-
bidity has primarily been demonstrated with
people who have cardiopulmonary disease
and asthma. Clearly, there is a need to better
understand the underlying mechanisms
responsible for these effects by performing
in vivo and in vitro exposure studies with a
variety ofparticles comparing the responses
ofasthmatics to normal subjects.
Ozone
Ozone (03) is a gas that occurs with other
photochemical oxidants and fine particles
in the complex mixture called smog.
Ozone is formed by a series ofsun-driven
reactions involving nitrogen oxides (NOX)
and volatile organic compounds (VOC)
arising largely from mobile and stationary
combustion sources (52-54). As a potent
oxidant, 03 is capable of reacting with a
variety of extracellular and intracellular
molecules, particularly those containing
thiol or amine groups or unsaturated C=C
bonds (55).
Bates and Sizto (56) studied hospital
admissions in southern Ontario, Canada,
an area with a population of 7 million
people and observed increased rates of
admissions for asthmatic subjects in the
summer, which correlated with both 03
and suspended sulfates. These results
implicate 03 as a contributing cause of
asthma admissions; however, the study
design could not separate the 03 effects
from concomitant effects of acidic aerosol
and SO2 (56,57). A more recent study by
Spektor et al. (58) found significant
decreases in peak flow and FEV1 in chil-
dren in summer camp, although the 03
concentration during the study period did
not exceed 0.12 ppm. None ofthe children
were reported to have ahistoryoflungdisease
or atopy.
Over the last 15 years, controlled
human exposure studies have clearly
demonstrated that the lung responds to 03
exposure by irritative cough and substernal
chest pain on inspiration; decrements in
forced vital capacity (FVC) and FEV1;
increase in specific airway resistance
(SRaw) and airway responsiveness; and
neutrophilic inflammation of the airway
submucosa accompanied by increased level
of mediators and cytokines in the BAL
(59). Even among homogeneous study
populations, there has been a wide range of
susceptibility to these effects (60,61).
Many clinical studies have failed to
show that subjects with asthma are more
sensitive to 03 than are healthy subjects
(62-64). These studies have typically
involved subjects with clinically mild
asthma performing mild exercise, and
those studies focused on spirometric
abnormalities. Recent data suggest that if
more intense exercise is imposed, asthmatic
subjects show increased SRaw to a 2-hr
exposure to 0.4 ppm 03 (65,66), which is
in excess ofthe response seen in nonasth-
matics.
A number ofstudies have addressed the
effects of03 following an exposure to or in
the presence of other pollutants. A few
controlled human exposure studies
addressing the interaction between 03 and
other criteria pollutants have been per-
formed. Prior exposure ofhealthy individ-
uals to other pollutants may modify the
response to 03 (67). Similarly, preexpo-
sure to 03 may change a response to other
pollutants. Recently, preexposure to 0.12
ppm 03 for 45 min followed by 0.10 ppm
SO2 for 15 min elicited greater bronchial
hyperreactivity in adolescent asthmatics
than SO2 alone or 03 exposure followed
by 03 (68). Exposures to mixtures con-
taining acid aerosols and 03 have shown
modestly increased effects (20,69). For
example, lung function, as measured by
spirometry was worse (70) when 03 was
inhaled with SO2 than with either alone,
although this study has not been repli-
cated. Very few studies focusing on the
effects ofexposure to mixtures on asthmat-
ics have been carried out so far. However,
the concept of influencing the asthmatic
response by combining exposure to 03
with a challenge ofa specific allergen has
created a lot of interest in the potential
indirect effects of 03 exposure. In one
study, individuals with allergic rhinitis
were initially exposed to clean air or 0.5
ppm 03 for 4 hr (71). The high level
exposure to 03 did not enhance the acute
response to antigen in the nose under these
experimental conditions. In a more recent
study, Molfino et al. (72) examined the
effect of03 without exercise on the airway
response to inhaled allergen in adult sub-
jects with asthma. They reported 03-
induced increases in bronchial
responsiveness to inhaled ragweed or grass
pollen as measured by allergen bron-
choprovocation tests. This is a very
provocative study that needs to be
confirmed. Along the same line of experi-
ments, studies are currently being con-
ducted examining the effects of
preexposure to 03 and exercise followed by
a nasal allergen challenge (using house dust
mite as antigen) on atopic asthmatics (73).
Preliminary data from those studies suggest
that the exposure to 03 before the nasal
challenge caused a shift in the dose ofaller-
gen needed to induce symptoms and
caused an increase in the levels of
inflammatory cytokines detected in the
nasal lavage.
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In developing future programs
intended to better understand the effects of
03 on asthma, there is a need to do longi-
tudinal and cross-sectional population
studies, clinical exposure studies including
nasal and bronchial challenges with aller-
gen, and in vitro studies that will be pri-
marily done to address mechanistic aspects
of environmental asthma and how the
epithelial cells from asthmatics may differ
from normal epithelial cells. Future studies
should also recognize the fact that 03 is
not only an outdoor air pollutant, but is
also present in the indoor air environment
(albeit at lower concentrations) where we
spend most ofour time.
Nitrogen Dioxide
Nitrogen dioxide (NO2) is an oxidant that
contaminates ambient air in many urban
and industrial locations and indoor air in
homes with unvented combustion appli-
ances. The present NAAQS refers to the
annual average concentration; a short-term
standard is not in place. However, some
evidence, largely from studies ofthe effects
ofacute exposure to NO2 on lung function
and airway responsiveness ofasthmatics,
suggests that a new standard governing
short-term concentrations may be
warranted.
During high temperature combustion,
oxygen reacts with nitrogen to generate
nitric oxide (NO) and, to a lesser extent
nitrogen dioxide (NO2) and other nitrogen
oxides. NO2 is highly reactive and, in the
presence ofsunlight, it participates with
hydrocarbons and oxygen in the complex
reactions that form 03 and other photo-
chemical oxidants. The principal source of
NO and NO2 in outdoor air is motorvehi-
cle emissions, but power plants and fossil-
fuel-burning industries also contribute. In
most U.S. cities, ambient levels ofNO2
vary with traffic density. Of 163 counties
reporting NO2 monitoring data, only Los
Angeles County did not meet the NAAQS
of0.053 ppm annual arithmetic mean. In
contrast to other criteria pollutants, NO2 is
awidespread contaminant ofindoor as well
as outdoor air, and indoor levels can exceed
those outdoors. Indoor sources ofNO2
include cooking ranges (74) and kerosene
space heaters (75). Because over one-half
ofthe residences in the United States have
gas cooking stoves and Americans spend a
large proportion of time in their homes,
the residential environment has generally
been found to be the most important con-
tributor to the population's total exposure
to NO2 (76,77). The toxicity ofNO2 is
generally attributed to oxidative capabilities
(78,79), although as an oxidant it is less
reactive than 03 (78,80). Empirical and
theoretical studies indicate that NO2 pene-
trates to the lung periphery, with the cen-
triacinar region as its primary deposition
site, and has a somewhat greater airway
deposition than 03 due to its higher
solubility inwater (81,82).
Only a few epidemiologic studies have
directly addressed the association between
NO2 concentration in outdoor air and res-
piratory illness. Much more extensive
information is available from studies exam-
ining the effects ofindoor exposures result-
ing from emissions from gas cooking stoves
and space heaters (83-85). The evidence
for a relationship between exposure to
NO2 and respiratory illness from studies of
indoor exposure does not consistently indi-
cate an increased incidence ofmore severe
illness in children and adults classified as
having higher exposures to NO2 (85-87).
The evidence is more abundant for chil-
dren. While several studies showed
significantly increased risk of respiratory
illness for children living in homes with gas
stoves compared with children living in
homes with electric stoves (88,89), other
studies did not (84,90-93). Metaanalysis
summarizing data from 11 epidemiologic
studies ofhealth effects associated with NO2
showed a significant association between
estimated NO2 exposure and illness (94).
Studies examining responses ofhealthy
volunteers to acute exposure to NO2
(< 1 ppm) have generally failed to show
alterations in lung mechanics ofhealthy
volunteers (95,96). Several recent observa-
tions indicate that NO2 exposures in the
range of 1.5 to 2.0 ppm cause small but
significant increases in airway reactivity.
Mohsenin (97) found that a 1-hr exposure
to 2 ppm 02 increased responsiveness to
methacholine, as measured by changes in
airway responsiveness, without directly
affecting lung function.
Early findings (98) brought attention
to the intriguing possibility that a relatively
brief exposure ofasthmatics to low-level
NO2 (0.1 ppm) might enhance subsequent
responsiveness to bronchial challenge with
a bronchoconstricting drug, although these
results could not be replicated in a later
study (99). Kleinman et al. (100) have
shown that inhalation of0.2 ppm NO2 for
2 hr, although not causing alterations in
flow rates or airway resistance, resulted in
increased reactivity to methacholine. Bauer
et al. (101) reported that NO2 inhalation
produced significant decrements in forced
expiratory flow rates after exercise and
increased responsiveness to cold air chal-
lenge. Despite this evidence of hyperre-
sponsiveness ofasthmatics to low levels of
NO2, considerable controversy remains
because ofthe inconsistency of the results
(59). The effects of NO2 exposure on
S02-induced bronchoconstriction have
been examined, but with inconsistent
results. Collectively, the findings reported
above differ from those of Linn et al.
(102,103), for asthmatics inhaling concen-
trations ofNO2 as high as 4.0 ppm. It is
evident that a wide range of responses
occur among asthmatics exposed to NO2.
This variation may in part reflect differ-
ences in subjects and exposure protocols.
However, the consistency of responses of
asthmatics to NO2 across a 1-year interval
suggests that some asthmatics are inher-
ently more responsive and implies a need
for better understanding of NO2 and
asthma (104).
NO2 appears to be much less potent
than 03 in eliciting a neutrophilic
inflammatory response in normal subjects.
Two preliminary reports (105,106)
describe increases in numbers of PMNs
obtained by BAL following a single 4- or
6-hr exposure to 2.0 ppm N02 Devlin et
al. (105), observed the increase in PMN
only in the cells recovered from the
bronchial lavage aliquot. The effect of
NO2 on challenges with a specific allergen
in atopic asthmatics is of considerable
interest considering the recent data by
Molfino et al. (72) and Peden et al. (73).
Responses to NO2 exposure in clinical
studies are characterized by marked vari-
ability, which directs attention toward
identifying determinants ofsusceptibility.
Characterizing these and other factors may
hold the key to understanding the risks of
NO2 exposure, especially to sensitive sub-
populations such as asthmatics.
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